(R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B.

[1]  M. Youdim.  The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction , 1995, Acta psychiatrica Scandinavica. Supplementum.

[2]  M. Brin,et al.  Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.

[3]  A. Boulton,et al.  Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors. , 1992, Journal of medicinal chemistry.

[4]  G. Engberg,et al.  Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons. , 1991, The Journal of pharmacology and experimental therapeutics.

[5]  M. Youdim,et al.  TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE B , 1981, British journal of pharmacology.

[6]  M. Youdim,et al.  SELECTIVE ACETYLENIC ‘SUICIDE’ AND REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE TYPES A AND B , 1981, British journal of pharmacology.

[7]  Y. Martin,et al.  Regression analysis of the relationship between physical properties and the in vitro inhibition of monoamine oxidase by propynylamines. , 1975, Journal of medicinal chemistry.

[8]  Y. Kobayashi,et al.  RADIOISOTOPIC ASSAY FOR MONOAMINE OXIDASE DETERMINATIONS IN HUMAN PLASMA. , 1964, Biochemical pharmacology.

[9]  E. Polymeropoulos.  l-Deprenyl: A Unique MAO-B Inhibitor , 1993 .

[10]  I. Szelenyi.  Inhibitors of monoamine oxidase B , 1993 .